Johnson & Johnson / Vector Laboratories / Leonard Guarente1 Paul F. Glenn Laboratory / Young AB / Thermo Fisher Scientific / Millipore / Proc Natl Acad Sci U S A / Furukawa / Armour / QIAGEN / antiJackson Laboratory / Cashikar AG / Guarente LP / Kazantsev AG / Broadley SA / Bio-Rad / /
Currency
USD / / /
Event
Product Issues / /
Facility
Massachusetts General Hospital / Massachusetts Institute of Technology / MassGeneral Institute / /
synucleinopathy including dementia / JE / dementia / neurodegenerative disease / dysfunction / amyotrophic lateral sclerosis / Lewy neuritis / MS / neurodegenerative disorders / Mitochondrial dysfunction / Alzheimer’s disease / disease / shock / multiple system atrophy / severe movement disorder / Parkinson’s disease / diseases / familial Alzheimer’s disease / neurodegenerative diseases / inflammation / human misfolding diseases / heat shock / human Lewy body diseases / /
MedicalTreatment
drug therapies / /
Organization
Harvard Medical School / MassGeneral Institute for Neurodegenerative Disease / National Institute of Health / RJG Foundation / Department of Biology / Massachusetts General Hospital / Massachusetts Institute of Technology / Glenn Foundation for Medical Research / 3Whitehead Institute for Biomedical Research / Department of Neuroscience / American Parkinson Disease Association / Tufts University School of Medicine / /
Person
Joseph Mazzuli / Leonard Guarente / Abdullah Yalcin / /
124 • The Journal of Neuroscience, January 4, 2012 • 32(1):124 –132 Neurobiology of Disease SIRT1 Protects against !-Synuclein Aggregation by Activating Molecular Chaperones